DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Hydroxytyrosol Modulates Arachidonic Acid Metabolism and Purine Catabolism in Individuals with Prediabetes: An Untargeted Metabolomics Study in a Randomized Controlled Trial
This article belongs to the Special Issue Exploring New Frontiers in Oxidative Stress and Antioxidant Research: From Model Organisms to Human Disease., [Data Availability Statement]
The data for this article, including all the raw data used in the generation of tables and figures (also those provided as ESI†), are available at the public repository digital.csic.es of the Spanish Research Council (CSIC) at https://doi.org/10.20350/digitalCSIC/17951., [Background:] Hydroxytyrosol (HT) is a phenolic compound found in extra virgin olive oil that modulates oxidative and inflammatory status. However, clinical trials evaluating HT as a stand-alone supplement remain scarce, and its underlying mechanisms and pathway modulation are not yet fully understood. This study aimed to investigate the metabolic effects of HT supplementation in individuals with overweight and prediabetes using an untargeted metabolomics approach., [Methods:] An untargeted liquid chromatography–mass spectrometry (LC–MS)-based metabolomics analysis was performed on serum samples from 49 participants with overweight and prediabetes enrolled in a randomized controlled trial. Participants received either HT (15 mg/day for 16 weeks; n = 24) or placebo (n = 25). Global metabolomic profiling was used to compare metabolic changes between the two groups., [Results:] HT supplementation induced a distinct metabolic profile compared with placebo. Participants in the HT group showed reduced levels of nitrogenous base derivatives and arachidonic acid, together with increased concentrations of phosphatidylcholines, lysophosphatidylcholines and sphingomyelins. These alterations suggest modulation of two key metabolic pathways including purine degradation and arachidonic acid metabolism., [Conclusions:] These findings provide mechanistic insights into the biological effects of HT and support the integration of metabolomics and multi-omics approaches in future clinical studies to validate these pathways in larger populations., This work was supported by grants PID2021-125259OB-I00 and PID2024-155959OB-I00 funded by MICIU/AEI/10.13039/501100011033 and by “ERDF/EU”. This work was also supported by CIBERDEM (CB07/08/0013), Instituto de Salud Carlos III, MCIN. I.M.-R is the recipient of an FPU contract from the predoctoral program (FPU23/00141) of Spanish Ministry of Science, Innovation and Universities., Peer reviewed